Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation

NCT: NCT07842601 · NOT_YET_RECRUITING

NCT IDNCT07842601
StatusNOT_YET_RECRUITING
Start Date2026-10-15
Completion2028-12-31
SponsorUniversity of Kentucky (OTHER)
First posted
Last updated

Brief Summary

This study will compare transcranial magnetic stimulation (TMS) with sham TMS in people with opioid use disorder who are taking buprenorphine and have major depressive disorder with ongoing depressive symptoms. The study will evaluate whether TMS improves depressive symptoms and reduces opioid craving. The study will also assess smoking behaviors, treatment acceptability, and any side effects related to TMS.

Frequently Asked Questions

What is Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation?

Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation is a clinical trial registered under NCT07842601. Current status: NOT_YET_RECRUITING.

What is the status of NCT07842601?

The current status of NCT07842601 (Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation) is: NOT_YET_RECRUITING.

When did Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation start?

Helping Kentuckians Overcome Depression and Opioid Addiction With Brain Stimulation started on 2026-10-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑